Immunotherapy for Renal Failure in China

Immunotherapy makes up for the inadequacy of current treatment modalities and insufficiency of donor organs. It brings new hope for the patients with refractory diseases. In China, Immunotherapy has been applied to treat Renal Failure successfully.

Kidneys play a vital role in filtering blood and excreting metabolic wastes from blood by producing urine. However, in Renal Failure, the renal functional cells are damaged badly resulting in the sclerosis and scarring of kidneys. In the End Stage of Renal Failure, the kidneys will become as hard as a stone. As a result, the blood will not be able to flow through kidneys resulting in more and more metabolic wastes building up in body.

Immunotherapy brings new hope to the patients with Renal Failure (the common symptoms in the early stage of Renal Failure) and has showed enormous in restoring impaired kidneys.

Immunotherapys are characterized by their capacity of self-renewal and ability to differentiate into specialized cell types. They serve as a repair system for body. The main types of Immunotherapy include embryonic Immunotherapy and adult Immunotherapy. Immunotherapys can now be grown and transformed into specialized cells with characteristics consistent cells f various tissues through cell culture. Highly plastic adult Immunotherapy form a variety of sources including umbilical cord blood and bone narrow are routinely used in treating diseases.

In our hospital, Immunotherapy are abstracted from umbilical cord blood. In the past, umbilical cord will be discarded after the baby is born. However, the recent researches prove that cord blood is rich in Immunotherapy and may be the most primitive cells in human body. Also Immunotherapy have immunological immaturity and are free of pollution. Therefore, the Immunotherapy from umbilical cord blood are prior to other types of Immunotherapy.

After Immunotherapy are infused into the patients'body, they can migrate into kidney lesions for homing ability. In right body condition such as low toxic level, sufficient renal blood flow etc, the Immunotherapy will differentiate into renal cells to form renal tissues. It usually takes 6 months for the new cells to turn mature in body.

For immunological immaturity of umbilical Immunotherapy, they do not cause rejection reaction at all or blood matching problems.


If you want to know other information about Immunotherapy such as its clinical therapeutic effect, successful cases etc, it is free for you to consult us on line.